Bruker Corp (BRKRP) KPIs and segments
Close on Nov 16, 2026Market cap $9.40BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Bruker's business
Bruker's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSI CALID($M) | 310 | 316 | 332 | 313 | 286 | 280 | 321 | 279 | 266 | 228 | |||
BSI NANO($M) | 261 | 246 | 309 | 267 | 252 | 257 | 318 | 287 | 253 | 240 | |||
BSI BioSpin($M) | 196 | 198 | 267 | 209 | 195 | 208 | 272 | 233 | 218 | 183 | 198 | ||
BEST($M) | 74.2 | 66.8 | 71.5 | 73.8 | 66.3 | 59.3 | 72.1 | 68.7 | 69.1 | 73.1 | 75.2 | 70.6 | |
Earlier reporting (last reported 2024)2 | |||||||||||||
Product($M) | 664 | 646 | 797 | 691 | 635 | 643 | 809 | 709 | 654 | 587 | 716 | 615 | |
Service and other revenue($M) | 175 | 177 | 180 | 169 | 163 | 158 | 171 | 155 | 146 | 135 | 139 | 128 | |
United States($M) | 248 | 222 | 225 | 226 | 223 | 217 | 261 | 239 | 244 | 195 | 212 | 211 | |
Europe excluding Germany($M) | 244 | 259 | 272 | 241 | 213 | 224 | 287 | 216 | 192 | ||||
Asia Pacific excluding China($M) | 112 | 135 | 163 | 131 | 127 | 131 | 164 | 141 | 106 | ||||
China($M) | 105 | 74 | 138 | 122 | 115 | 101 | 114 | 121 | 120 | 116 | 167 | 137 | |
Germany($M) | 64.4 | 62.7 | 106 | 71.3 | 59.1 | 61.1 | 86.1 | 74.3 | 83.5 | 66.8 | 79.4 | 78 | |
Other($M) | 64.3 | 71.2 | 74 | 69.5 | 59.9 | 66.2 | 67.5 | 73.1 | 54.6 | 59.3 | 62 | 50.4 | |
Earlier reporting (last reported 2025)2 | |||||||||||||
BSI CALID($M) | 72.3 | 62.6 | 71.7 | 76 | 53.3 | 61.5 | 78 | 58.7 | 58.4 | 51.1 | 80.5 | 50 | |
BSI BioSpin($M) | 41.7 | 28.8 | 63 | 33.3 | 23.1 | 37.1 | 78.6 | 56.8 | 46.6 | 34.6 | 87.5 | 52.5 | |
BSI NANO($M) | 29.8 | 14.4 | 45.1 | 23.5 | 9.40 | 23.1 | 44.1 | 30.6 | 19.2 | 29.8 | 58.7 | 39 | |
BEST($M) | 7.60 | 7.60 | 5.50 | 7 | 7.20 | 7 | 8.60 | 7.70 | 10.6 | 8.20 | 4.40 | 9 | |
Product($M) | 331 | 299 | 368 | 302 | 289 | 321 | 411 | 360 | 328 | 295 | 374 | 322 | |
Service and other revenue($M) | 84.6 | 81 | 81 | 77.3 | 69.3 | 70.2 | 82.2 | 58.8 | 56.2 | 57.6 | 56.7 | 60.7 | |
BSI BioSpin($M) | 0 | -2.40 | -1.10 | -4.80 | -2.30 | -3.20 | -6 | -13.4 | -3.80 | 0.40 | |||
BEST($M) | -2.80 | -1.60 | -4.50 | -2.10 | -2.40 | -4.80 | -6.30 | -4.20 | -6.30 | -7.60 | |||
Corporate($M) | -3.50 | -2.30 | -2.90 | -1.50 | -6.90 | -4.70 | -3.70 | -4.20 | -4 | -2.70 | |||
BSI CALID($M) | -6.50 | -6.70 | -4.30 | -7.10 | -5.50 | -8.40 | -15.8 | -6.50 | -6.40 | -5.30 | |||
BSI NANO($M) | -7.50 | -4.90 | -15.3 | -3.10 | -13.2 | -4.90 | -4.90 | -4.30 | -4 | -6.20 | |||
BSI BioSpin, BSI CALID, BSI NANO & Corporate($M) | 5,902 | 5,978 | 6,094 | 6,287 | 6,193 | 5,769 | 5,648 | 4,111 | |||||
BEST($M) | 194 | 195 | 192 | 191 | 191 | 205 | 200 | 198 | 179 | 180 | 186 | 169 | |
Remaining performance obligations (RPO)($M) | 2,776 | 2,708 | 2,569 | 2,079 | 2,109 | 2,072 | 2,207 | 2,258 | 2,306 | 2,189 | |||
7 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-05.
See a number that looks wrong?